cerrar
Tagged with Global

Muhammad Ali Pate – Global Director for Health, Nutrition…
Dr Muhammad Ali Pate, Global Director for Health, Nutrition and Population at the World Bank as well as Director of the Global Financing Facility for…

J&J’s Momenta Deal A Further Sign of Big Pharma’s Rare…
In the wake of Sanofi’s USD 3.7 billion tie-up for US biotech Principia, J&J has moved to bolster its autoimmune portfolio with the acquisition…

Pharma Faces: Teresa Rodó, Head of Global Healthcare Operations,…
PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to unpack her important role within the…

When Health Policy Becomes Industrial Policy
In his latest piece, Brendan Shaw casts his eye over why those drawing up health policies need to start incorporating issues of industrial policy into…

Understanding the Value of Patient Engagement
Jessica Scott, Takeda’s head of R&D patient engagement, highlights how a better understanding of the value of patient engagement across the…

The End of “Digital” as a Story of Value
John G. Singer examines why technological solutions are not a quick fix to overcoming the COVID-19 crisis and how a systems shift is crucial to…

Bill Sibold – Executive Vice President, Sanofi Genzyme
Speaking exclusively to PharmaBoardroom, Sanofi Genzyme Executive VP Bill Sibold outlines Sanofi’s strategy for its specialty care unit, the wealth…

Roche: Back on Top of The Global Biopharma Rankings
Swiss giant Roche tops Pharmaceutical Executive's 2020 list of the world's biggest pharma companies, up from second place in 2019 and third in 2018.…

Can We Afford to Pay for Future Cures?
Pharmaceutical innovation is racing ahead of the US health system's ability to adjust payment models, but innovative concepts are finally emerging. We…

Teresa Rodó – EVP, Head of Global Healthcare Operations,…
Teresa Rodó gives an overview of her role overseeing the development, manufacturing, supply, and quality of all of Merck’s biotech and…

New Billion Dollar Pharma Action Fund to Counter ‘Slow…
June 9th 2020 saw the launch of a new action fund on antimicrobial resistance (AMR), with 23 leading biopharmaceutical companies committing to almost…

GSK: Senior VP for Vaccines R&D on COVID-19 Collaboration
GSK, the world’s largest manufacturer of vaccines, has pursued a different strategy to that of its contemporaries in the effort to develop a safe,…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here